223 related articles for article (PubMed ID: 24269730)
1. Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down syndrome.
Begenisic T; Baroncelli L; Sansevero G; Milanese M; Bonifacino T; Bonanno G; Cioni G; Maffei L; Sale A
Neurobiol Dis; 2014 Mar; 63():12-9. PubMed ID: 24269730
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice.
Stagni F; Giacomini A; Guidi S; Ciani E; Ragazzi E; Filonzi M; De Iasio R; Rimondini R; Bartesaghi R
Neurobiol Dis; 2015 Feb; 74():204-18. PubMed ID: 25497735
[TBL] [Abstract][Full Text] [Related]
3. Adult-onset fluoxetine treatment does not improve behavioral impairments and may have adverse effects on the Ts65Dn mouse model of Down syndrome.
Heinen M; Hettich MM; Ryan DP; Schnell S; Paesler K; Ehninger D
Neural Plast; 2012; 2012():467251. PubMed ID: 22848851
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome.
Clark S; Schwalbe J; Stasko MR; Yarowsky PJ; Costa AC
Exp Neurol; 2006 Jul; 200(1):256-61. PubMed ID: 16624293
[TBL] [Abstract][Full Text] [Related]
5. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
Kleschevnikov AM; Yu J; Kim J; Lysenko LV; Zeng Z; Yu YE; Mobley WC
Neurobiol Dis; 2017 Jul; 103():1-10. PubMed ID: 28342823
[TBL] [Abstract][Full Text] [Related]
6. Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome.
Rueda N; Flórez J; Martínez-Cué C
Neurosci Lett; 2008 Mar; 433(1):22-7. PubMed ID: 18226451
[TBL] [Abstract][Full Text] [Related]
7. Reducing GABAA α5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome.
Martínez-Cué C; Martínez P; Rueda N; Vidal R; García S; Vidal V; Corrales A; Montero JA; Pazos Á; Flórez J; Gasser R; Thomas AW; Honer M; Knoflach F; Trejo JL; Wettstein JG; Hernández MC
J Neurosci; 2013 Feb; 33(9):3953-66. PubMed ID: 23447605
[TBL] [Abstract][Full Text] [Related]
8. Early environmental therapy rescues brain development in a mouse model of Down syndrome.
Begenisic T; Sansevero G; Baroncelli L; Cioni G; Sale A
Neurobiol Dis; 2015 Oct; 82():409-419. PubMed ID: 26244989
[TBL] [Abstract][Full Text] [Related]
9. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C
Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic administration of SGS-111 during adulthood and during the pre- and post-natal periods on the cognitive deficits of Ts65Dn mice, a model of Down syndrome.
Rueda N; Flórez J; Martínez-Cué C
Behav Brain Res; 2008 Apr; 188(2):355-67. PubMed ID: 18178265
[TBL] [Abstract][Full Text] [Related]
11. Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.
Roncacé V; Burattini C; Stagni F; Guidi S; Giacomini A; Emili M; Aicardi G; Bartesaghi R
Neurobiol Dis; 2017 Oct; 106():89-100. PubMed ID: 28651891
[TBL] [Abstract][Full Text] [Related]
12. Macrophage migration inhibitory factor is critically involved in basal and fluoxetine-stimulated adult hippocampal cell proliferation and in anxiety, depression, and memory-related behaviors.
Conboy L; Varea E; Castro JE; Sakouhi-Ouertatani H; Calandra T; Lashuel HA; Sandi C
Mol Psychiatry; 2011 May; 16(5):533-47. PubMed ID: 20177408
[TBL] [Abstract][Full Text] [Related]
13. Aerobic exercise and a BDNF-mimetic therapy rescue learning and memory in a mouse model of Down syndrome.
Parrini M; Ghezzi D; Deidda G; Medrihan L; Castroflorio E; Alberti M; Baldelli P; Cancedda L; Contestabile A
Sci Rep; 2017 Dec; 7(1):16825. PubMed ID: 29203796
[TBL] [Abstract][Full Text] [Related]
14. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.
Guidi S; Stagni F; Bianchi P; Ciani E; Giacomini A; De Franceschi M; Moldrich R; Kurniawan N; Mardon K; Giuliani A; Calzà L; Bartesaghi R
Brain; 2014 Feb; 137(Pt 2):380-401. PubMed ID: 24334313
[TBL] [Abstract][Full Text] [Related]
15. Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome.
Corrales A; Vidal R; García S; Vidal V; Martínez P; García E; Flórez J; Sanchez-Barceló EJ; Martínez-Cué C; Rueda N
J Pineal Res; 2014 Jan; 56(1):51-61. PubMed ID: 24147912
[TBL] [Abstract][Full Text] [Related]
16. Object recognition memory is conserved in Ts1Cje, a mouse model of Down syndrome.
Fernandez F; Garner CC
Neurosci Lett; 2007 Jun; 421(2):137-41. PubMed ID: 17566652
[TBL] [Abstract][Full Text] [Related]
17. Memantine normalizes several phenotypic features in the Ts65Dn mouse model of Down syndrome.
Rueda N; Llorens-Martín M; Flórez J; Valdizán E; Banerjee P; Trejo JL; Martínez-Cué C
J Alzheimers Dis; 2010; 21(1):277-90. PubMed ID: 20421694
[TBL] [Abstract][Full Text] [Related]
18. Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome.
Di Filippo M; Tozzi A; Ghiglieri V; Picconi B; Costa C; Cipriani S; Tantucci M; Belcastro V; Calabresi P
Biol Psychiatry; 2010 Apr; 67(7):666-71. PubMed ID: 19818432
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy with fluoxetine restores functional connectivity from the dentate gyrus to field CA3 in the Ts65Dn mouse model of down syndrome.
Stagni F; Magistretti J; Guidi S; Ciani E; Mangano C; Calzà L; Bartesaghi R
PLoS One; 2013; 8(4):e61689. PubMed ID: 23620781
[TBL] [Abstract][Full Text] [Related]
20. Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome.
Velazquez R; Ash JA; Powers BE; Kelley CM; Strawderman M; Luscher ZI; Ginsberg SD; Mufson EJ; Strupp BJ
Neurobiol Dis; 2013 Oct; 58():92-101. PubMed ID: 23643842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
